TYPE I GLYCOGEN STORAGE DISEASE
Glycogen
Storage Disease has been divided into at least 10 different types based
on the deficiency of a particular enzyme which controls blood sugar
levels.
Type
I Glycogen Storage Disease is a deficiency of the enzyme glucose -6
- phosphatase which helps in maintaining a normal blood glucose (sugar
concentration) during fasting. Patients with this particular disorder
show a large number of abnormalities which exhibit themselves in growth
failure, a greatly enlarged liver, and a distended (swollen) abdomen.
The abnormal blood chemical condition is indicated by low blood sugar
concentration and higher than normal levels of lipids and uric acid.
In
the past, these patients have been treated by frequent feedings during
the daytime and occasional feedings during the normal sleeping hours
which required waking the patient. This was the accepted form of therapy
until 1966 to 1967, but the patients continued to show various difficulties
in physical development and blood chemistry.
Starting
in 1967, surgeons began performing a surgical procedure, called a portacaval
shunt, which bypassed the blood around the liver. In some patients this
procedure resulted in improvement in observable physical condition and
improved biochemical levels in the blood. In 1974 it was found that
patients also did exceedingly well if the blood glucose level was maintained
within the normal range by frequent daytime feedings and by continuous
infusion of a solution high in glucose concentration into the stomach
during the night. Maintenance of the blood glucose level either in total
intravenous feedings or by continuous infusion of high glucose-containing
foods into the stomach could reverse all of the physical and chemical
signs of this disease.
A
practical management technique for maintaining the blood glucose level
has been devised in which a naso-gastric tube is inserted into the stomach
each evening and through this tube is infused a solution containing
a high concentration of glucose so the blood sugar level remains between
75 and 120. In the daytime the tube is removed and the patient eats
a high starch meal approximately every 2-1/2 to 3-1/2 hours. Using this
technique, most of the physical and biochemical abnormalities are completely
reversed.
One
study in which a total of 14 patients were followed, nine for a period
of greater than 5 years, has shown this to be an effective form of treatment.
Although younger children will have to use the tube each evening, doctors
feel that this may not be necessary past puberty.

The
American Liver Foundation is the only national voluntary nonprofit health
organization dedicated to treating, curing, and preventing hepatitis
and other liver and galllbladder diseases through research and education.
American
Liver Foundation
1425 Pompton Avenue
Cedar Grove, New Jersey 07009
1-800-223-0179
Copyright
© 1995 The American Liver Foundation
|